Gaudium IVF Files Corrigendum for FY26 Financial Results
Gaudium IVF and Women Health Ltd has submitted a corrigendum to its consolidated financial results for the quarter and year ended March 31, 2026. The correction addresses inadvertent regrouping and typographical errors in comparative figures for the previous financial year ended March 31, 2025, specifically within the Consolidated Balance Sheet and Statement of Profit and Loss. The company clarifies that standalone results were accurate, and the overall figures for March 31, 2026, remain unchanged. The errors are clerical and do not impact the Profit After Tax, Net Worth, or overall financial position for the current period. The statutory auditors have confirmed the rectifications are limited to comparative figures and do not necessitate updating their report.
Key Highlights
- Corrigendum filed for FY26 consolidated financial results.
- Errors were clerical, affecting comparative FY25 figures.
- Standalone results and FY26 consolidated figures remain unchanged.
- No impact on Profit After Tax or Net Worth.
- Auditors confirm no revision needed for their report.
Price Impact
More from GAUDIUMIVF